| 000 | 01837 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518080024.0 | ||
| 264 | 0 | _c20210104 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1096-1186 | ||
| 024 | 7 |
_a10.1016/j.phrs.2019.104623 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Ruihan | |
| 245 | 0 | 0 |
_aModified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD- L1-dependent T cell immunization. _h[electronic resource] |
| 260 |
_bPharmacological research _c02 2020 |
||
| 300 |
_a104623 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aB7-H1 Antigen _ximmunology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aDrugs, Chinese Herbal _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _ximmunology |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aWu, Jian | |
| 700 | 1 | _aZhang, Xingxing | |
| 700 | 1 | _aZou, Xi | |
| 700 | 1 | _aLi, Changyin | |
| 700 | 1 | _aWang, Hongxing | |
| 700 | 1 | _aYuan, Mengyun | |
| 700 | 1 | _aChen, Min | |
| 700 | 1 | _aSun, Qingmin | |
| 700 | 1 | _aLiu, Shenlin | |
| 773 | 0 |
_tPharmacological research _gvol. 152 _gp. 104623 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2019.104623 _zAvailable from publisher's website |
| 999 |
_c30481289 _d30481289 |
||